Myriad Genetics Inc (MYGN)
Debt-to-assets ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total assets | US$ in thousands | 1,027,600 | 1,146,500 | 1,198,700 | 1,320,700 | 1,418,800 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,027,600K
= 0.00
The debt-to-assets ratio for Myriad Genetics Inc has consistently remained at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized debt financing to fund its operations or acquire assets during this period. A debt-to-assets ratio of 0.00 suggests that the company's assets are primarily financed through equity rather than debt, reflecting a lower financial risk and potential for financial stability. However, it is important to note that a low debt-to-assets ratio may also imply missed opportunities for leveraging debt for potential growth and investment.
Peer comparison
Dec 31, 2024